Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nueva EPS is the largest government-backed health insurance provider in Colombia, covering over 10 million members. It operates within the Colombian public healthcare system as an intermediary that manages mandatory health plans and contracts with healthcare providers for service delivery[4][6]. The company has recently received regulatory support to negotiate pharmaceutical purchases jointly with other entities to improve cost efficiency[1][7]. In April 2024, the Colombian regulator assumed temporary administrative control of Nueva EPS to ensure compliance with financial obligations and payment processes. This intervention was preventive and did not affect ongoing operations or payments to providers[4]. The company plays a critical role in Colombia’s publicly funded healthcare system by channeling funds from the national pool (ADRES) to private healthcare service providers[4]. There are no clinical results or drug development activities associated with this entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nueva EPS.